Star Therapeutics
BiotechnologyWebsite
Developer of antibody-based therapeutics designed to treat serious and underserved diseases through novel biological pathways. The company offers a pipeline-in-a-product approach with proprietary anti...
Valuation
$0
Share Price
N/A
Total Raised
$315M
Last Round
Later Stage VC (Series D)
Sep 2025
Latest Funding Round
Later Stage VC (Series D)
Sep 22, 2025
$125M
raised
Investors
+19 other investors